J Pain Palliat Care Pharmacother. 2005;19(2):73-8.
The Federation of State Medical Boards of the United States published Model Guideline for the Use of Controlled Substances in the Management of Pain in 1998 and expanded it to this Model Policy in October 2004. The Model Policy is designed to communicate to licensees that the state medical board views pain management to be important and integral to the practice of medicine; that opioid analgesics may be necessary for the relief of pain; that the use of opioids for other than legitimate medical purposes poses a threat to the individual and society; that physicians have a responsibility to minimize the potential for the abuse and diversion of controlled substances; and that physicians will not be sanctioned solely for prescribing opioid analgesics for legitimate medical purposes.
美国各州医学委员会联合会于1998年发布了《疼痛管理中使用受控物质的示范指南》,并于2004年10月将其扩展为本示范政策。该示范政策旨在向持牌人传达,州医学委员会认为疼痛管理对医疗实践至关重要且不可或缺;阿片类镇痛药对于缓解疼痛可能是必要的;将阿片类药物用于非合法医疗目的对个人和社会构成威胁;医生有责任尽量减少受控物质被滥用和转移的可能性;并且医生不会仅因出于合法医疗目的开具阿片类镇痛药而受到制裁。